Citalopram NDC 65162-054

NDC codes

FDA NDC Directory

Product NDC (as listed)65162-054Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65162-0054Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
65162-054-03	65162005403	30 TABLET in 1 BOTTLE (65162-054-03)Marketed from Apr 6, 2010
65162-054-10	65162005410	100 TABLET in 1 BOTTLE (65162-054-10)Marketed from Apr 6, 2010
65162-054-11	65162005411	1000 TABLET in 1 BOTTLE (65162-054-11)Marketed from Apr 6, 2010
65162-054-50	65162005450	500 TABLET in 1 BOTTLE (65162-054-50)Marketed from Apr 6, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Citalopram
Generic name (nonproprietary): citalopram
Active ingredients: Citalopram hydrobromide — 40 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Amneal Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077289
Marketing start: Apr 6, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 65162-054_a42ab6f8-0664-4d9d-9da0-116bba7e55fcSPL ID a42ab6f8-0664-4d9d-9da0-116bba7e55fcSPL set ID 6a402640-1c9d-4fca-8b5b-e1ac1dd4ca5aRxCUI 200371, 283672, 309314UNII I1E9D14F36UPC 0365162053500, 0365162054507, 0365162052503
Pharmacologic class: Serotonin Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465162005403 followed by a unit qualifier and the quantity

Package 65162-0054-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 23, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Citalopram tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ]. Citalopram tablets are a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) in adults ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077289

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077289
Product	Strength	Form · route	Labeler	Product NDC
Citalopram	Citalopram hydrobromide 20 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	43063-063
Citalopram	Citalopram hydrobromide 10 mg/1	TabletOral	Amneal Pharmaceuticals LLC	65162-052
Citalopram	Citalopram hydrobromide 20 mg/1	TabletOral	Amneal Pharmaceuticals LLC	65162-053